Histocell is a Spanish clinical-stage biopharmaceutical company and CDMO specializing in regenerative medicine and advanced therapy medicinal products (ATMPs). Based in the Basque Country, the company develops and manufactures cell therapy products from iPSCs, MSCs, secretomes, and exosomes. Histocell recently achieved GMP certification from AEMPS for iPSC manufacturing in partnership with REPROCELL, and has produced over 350 GMP batches treating approximately 300 patients from its 800 m2 EMA-registered facility.
iPSC manufacturing, mesenchymal stem cell therapy, ATMP GMP manufacturing, exosome production, regenerative medicine
1 site worldwide
Involvement in 1 clinical trial
No reviews available yet.
No documents available.